持续静脉泵入呋塞米与多巴胺联合黄芪注射液治疗难治性心力衰竭患者利尿剂抵抗

目的:分析持续静脉泵入呋塞米和多巴胺结合黄芪注射液对难治性心衰病人治疗的利尿剂抵抗的作用。方法:以我院2017年3月到2018年3月收治的难治性心衰病人200例作为本次研究主体,所选取的病人全部为利尿抵抗病人,依据不同病人的不同入院时间分成对照组与实验组,每组病人100例。对照组病人通过使用利尿剂和抗心衰实施治疗,实验组病人则通过持续静脉泵入呋塞米与多巴胺和静脉滴入黄芪注射液实施治疗,对比分析两组病人心功能改善状况和治疗效果。结果:所有病人通过积极有效的治疗之后其指标改变和治疗之前对比都有一定程度的改善,同时实验组病人的改善更为明显,P<0.05。另外实验组病人的治疗有效率达到92.00%,优于对照组的72.00%,P<0.05。结论:持续静脉泵入呋塞米和多巴胺结合黄芪注射液对难治性心衰病人治疗临床效果较为明显。

objective:analysis of continuous intravenous pumping injunctions Sammy and dopamine combined with astragalus membranaceus injection for the treatment of refractory heart failure patients diuretic resistance.Methods:in our hospital in March 2017 to March 2018 were 200 cases of intractable heart failure patients as the research main body, all of the patients selected for diuretic resistance patients, according to different patients hospitalized time were divided into control group and experimental group, each group of 100 cases of patients.The control group patients through the use of diuretics and heart failure treatment, the patients through continuous intravenous pumping cefuroxime Sammy and dopamine and intravenous drip into the astragalus membranaceus injection treatment, compared two groups of patients with cardiac function improved condition and treatment effect.Results:all patients through positive and effective treatment after the index changes and treatment before contrast has a certain degree of improvement, at the same time, the improvement of the experimental group patients is more apparent, P < 0.05).In experimental group patients treatment efficiency reached 92.00%, 72.00% better than that of control group, P < 0.05).Conclusion:continuous intravenous pumping cefuroxime Sammy and dopamine combined with astragalus membranaceus injection for the treatment of refractory heart failure patients clinical effect is more obvious.